ASHLEY BLALOCK: Open Payments
NPI 1700476207 · MOULTRIE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,114 in 63 payments from 17 companies in 2025. Trend: 2023 $673 · 2024 $693 · 2025 $1,114
Food & beverage: $1,114
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $265 |
| Novo Nordisk Inc | 6 | $193 |
| SHIELD THERAPEUTICS INC | 13 | $157 |
| PFIZER INC. | 10 | $156 |
| Sumitomo Pharma America, Inc. | 1 | $84 |
| Lilly USA, LLC | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Medline Industries LP | 1 | $27 |
| Corcept Therapeutics | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: Ozempic, ACCRUFER, VRAYLAR, GEMTESA, UBRELVY, ELIQUIS, NURTEC ODT, JARDIANCE.
Industry payments across GA — which companies pay providers there.
